Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEA
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.
The research was led by Lisa Monteggia,…
Continue Reading
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News19 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General11 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final